Study of Safety and Efficacy of EGFR-TKI EGF816 in Combination With cMET Inhibitor INC280 in Adult Patients With EGFR Mutated Non Small Cell Lung Cancer.
Clinical trial NCT02335944 · TERMINATED
Trial details
- NCT number
- NCT02335944
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-13
- Primary completion
- 2020-11-10
- Enrollment
- 177
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.